M. Mostafi, Ahammad Shamir Shawrov, Mohammad Abdul Wahab, A. Saleh
{"title":"REGEN-COV™(Casirivimab和Imdevimab)联合Molnupiravir InStage- V CKD患者合并症状性COVID-19肺炎1例报告","authors":"M. Mostafi, Ahammad Shamir Shawrov, Mohammad Abdul Wahab, A. Saleh","doi":"10.47363/jone/2022(2)105","DOIUrl":null,"url":null,"abstract":"Combination of two human monoclonal antibodies, Casirivimab and imdevimab, commonly termed as Cocktail therapy recommended for the treatment and prevention of COVID-19. It is administered as an infusion or subcutaneous injection. Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. There is very limited data available regarding co administration of oral Molnupiravir along with intravenous REGEN-COV™ (Casirivimab and imdevimab) in CKD patient. Here, we report the successful outcome of REGEN-COV™ along with oral Molnupiravir in a CKD Stage V hospitalized patient with Symptomatic COVID-19 Pneumonia","PeriodicalId":415214,"journal":{"name":"Journal of Nephrology & Endocrinology Research","volume":"101 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"REGEN-COV™ (Casirivimab and Imdevimab) along with Molnupiravir InStage- V CKD Patient with Symptomatic COVID-19 Pneumonia: A Case Report\",\"authors\":\"M. Mostafi, Ahammad Shamir Shawrov, Mohammad Abdul Wahab, A. Saleh\",\"doi\":\"10.47363/jone/2022(2)105\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Combination of two human monoclonal antibodies, Casirivimab and imdevimab, commonly termed as Cocktail therapy recommended for the treatment and prevention of COVID-19. It is administered as an infusion or subcutaneous injection. Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. There is very limited data available regarding co administration of oral Molnupiravir along with intravenous REGEN-COV™ (Casirivimab and imdevimab) in CKD patient. Here, we report the successful outcome of REGEN-COV™ along with oral Molnupiravir in a CKD Stage V hospitalized patient with Symptomatic COVID-19 Pneumonia\",\"PeriodicalId\":415214,\"journal\":{\"name\":\"Journal of Nephrology & Endocrinology Research\",\"volume\":\"101 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Nephrology & Endocrinology Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47363/jone/2022(2)105\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nephrology & Endocrinology Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47363/jone/2022(2)105","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
REGEN-COV™ (Casirivimab and Imdevimab) along with Molnupiravir InStage- V CKD Patient with Symptomatic COVID-19 Pneumonia: A Case Report
Combination of two human monoclonal antibodies, Casirivimab and imdevimab, commonly termed as Cocktail therapy recommended for the treatment and prevention of COVID-19. It is administered as an infusion or subcutaneous injection. Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. There is very limited data available regarding co administration of oral Molnupiravir along with intravenous REGEN-COV™ (Casirivimab and imdevimab) in CKD patient. Here, we report the successful outcome of REGEN-COV™ along with oral Molnupiravir in a CKD Stage V hospitalized patient with Symptomatic COVID-19 Pneumonia
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
